• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Surveillance and Biometrics (OSB) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Data is current as of September 30, 2013

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercent
Oct 20108596
Nov 20108596
Dec 20108598
Jan 20118596
Feb 20118596
Mar 20118598
Apr 20118594
May 20118592
Jun 20118592
Jul 20118594
Aug 20118591
Sep 20118590

FY 2011 Overall: 94%

Number of OSB intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A259
Nov 2010N/A265
Dec 2010N/A287
Jan 2011N/A278
Feb 2011N/A255
Mar 2011N/A355
Apr 2011N/A303
May 2011N/A280
Jun 2011N/A282
Jul 2011N/A267
Aug 2011N/A273
Sep 2011N/A256

FY 2011 Total: 3,360

Total number of OSB intra- and inter-Office eConsults completed during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A270
Nov 2010N/A275
Dec 2010N/A293
Jan 2011N/A291
Feb 2011N/A265
Mar 2011N/A364
Apr 2011N/A323
May 2011N/A306
Jun 2011N/A307
Jul 2011N/A283
Aug 2011N/A299
Sep 2011N/A283

FY 2011 Total: 3,559

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.